Archive | October, 2009

Lifeline Estimates Six Months For FDA Response (PINK:LLBO)

26 October 2009 – 12:54 pm PST

View Comments

Lifeline Estimates Six Months For FDA Response (PINK:LLBO)

Lifeline Biotech (Public, PINK:LLBO) reported today about the status of their First Warning Systemâ„¢ 510(k) FDA application. The consulting firm, Lifeline Biotech used to submit the FDA application, advised that the “FDA is running anywhere from 30 to 60 days past the normal time expected to provide a response”.

Continue reading...

Novo Nordisk races ahead (NYSE:NVO)

26 October 2009 – 7:30 am PST

Comments Off

Novo Nordisk races ahead (NYSE:NVO)

Novo Nordisk A/S (ADR) (NYSE:NVO) has made an announcement that their diabetes treatment Liraglutide cuts weight and reduces health risks in obese non-diabetics.

Continue reading...

Theravance Milestone Payment (NASDAQ:THRX)

26 October 2009 – 6:45 am PST

Comments Off

Theravance Milestone Payment (NASDAQ:THRX)

Theravance, Inc. (NASDAQ:THRX) has announced that they have received a US$20 million milestone payment after their new drug telavancin was approved by the Food and Drug Administration panel.

Continue reading...

Alcon Takes Over Potentia (NYSE:ACL)

26 October 2009 – 6:00 am PST

Comments Off

Alcon Takes Over Potentia (NYSE:ACL)

Alcon, Inc. (NYSE:ACL) has announced that they have inked a licensing and purchasing agreement with Potentia Pharmaceuticals.

Continue reading...

GE Lands New Major Gas Project (NYSE:GE)

23 October 2009 – 1:35 pm PST

Comments Off

GE Lands New Major Gas Project (NYSE:GE)

General Electric Company (NYSE:GE) is really having a good week with favorable news of company’s growth from all around.

Continue reading...

GE’s Healthymagination (NYSE:GE)

23 October 2009 – 9:59 am PST

Comments Off

GE’s Healthymagination (NYSE:GE)

In one of the surprising news on Thursday, General Electric Company (NYSE:GE) has decided to launch a new US$250 million venture fund as an investment in new life sciences technologies along with Eli Lilly that will work on new cancer research.

Continue reading...

Amgen’s Plan for Denosumab (NASDAQ:AMGN)

23 October 2009 – 9:51 am PST

Comments Off

Amgen’s Plan for Denosumab (NASDAQ:AMGN)

On Thursday, Amgen, Inc. (NASDAQ:AMGN) have opened up about the new plans about how the company will actually handle the request for the new information asked by the Food and Drug Administration panel.

Continue reading...

Whirlpool profit higher than expected (NYSE:WHR)

23 October 2009 – 9:50 am PST

Comments Off

Whirlpool profit higher than expected (NYSE:WHR)

Whirlpool Corporation (NYSE:WHR) reported a higher than expected quarterly profit as cost cuts offset weak sales.

Continue reading...

Honeywell Profits Slides (NYSE:HON)

23 October 2009 – 9:39 am PST

Comments Off

Honeywell Profits Slides (NYSE:HON)

Honeywell International Inc. (NYSE:HON) announced that they have lowered their 2009 revenue guidance as they have reported a slide of 15 percent in their third quarter earnings.

Continue reading...

Microsoft Sales Slip (NASDAQ:MSFT)

23 October 2009 – 9:36 am PST

Comments Off

Microsoft Sales Slip (NASDAQ:MSFT)

You can purely call it a Microsoft magic that despite their sales have gone down, their shares on the market have soared higher than what the analysts had expected.

Continue reading...